Free tool
Diagnostics stocks
We cover 25 companies grouped under the Diagnostics theme. The median market value in the group is $1.04B. Across the group, the median move over the past trading day is −0.70%. 56% of the 25 with a 200-day average trade above it. Price change over the past year runs from −76.0% to +141.9% across the middle 80 percent of the group, with a median of −8.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
25 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% | Oct 28, 2026 |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% | Nov 3, 2026 |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% | Nov 4, 2026 |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% | Nov 5, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% | Nov 4, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% | Nov 3, 2026 |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% | Nov 11, 2026 |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% | Nov 3, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% | Oct 28, 2026 |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% | Nov 2, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% | Nov 6, 2026 |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% | Nov 2, 2026 |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% | Nov 4, 2026 |
| LUCD | Lucid Diagnostics Inc. | $185.35M | Small cap | −22.96% | Nov 11, 2026 |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +73.39% | Nov 9, 2026 |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% | Nov 16, 2026 |
| MDXH | MDxHealth SA | $72.15M | Micro cap | −84.51% | Nov 12, 2026 |
| PAVM | PAVmed Inc. | $42.54M | Micro cap | −63.21% | Nov 12, 2026 |
| CODX | Co-Diagnostics, Inc. | $8.73M | Micro cap | −87.22% | Nov 16, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.71M | Micro cap | −48.46% | Nov 6, 2026 |
| REVB | Revelation Biosciences, Inc. | $3.80M | Micro cap | −91.25% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.